P-290 Aberrant promoter hypermethylation of RUNX3 in non-small cell lung cancer confers adverse prognosis

Authors :: John D. Minna
Adi F. Gazdar
Hisayuki Shigematsu
Elizabeth Brambilla
Kuniharu Miyajima
Makoto Suzuki
Ubaradka G. Sathyanarayana
Takao Takahashi
Source :: Lung Cancer. 41:S165
Publication Year :: 2003
Publisher :: Elsevier BV, 2003.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Cancer
medicine.disease
Promoter hypermethylation
Internal medicine
medicine
Cancer research
Non small cell
Lung cancer
business

Full Text Access

Tools